CAS 590368-25-5
:Upamostat
Description:
Upamostat, with the CAS number 590368-25-5, is a synthetic small molecule that functions primarily as a protease inhibitor. It has garnered attention in the field of medicinal chemistry due to its potential therapeutic applications, particularly in the treatment of various diseases, including certain types of cancer and viral infections. The compound exhibits a specific mechanism of action by inhibiting serine proteases, which are enzymes that play critical roles in numerous biological processes, including cell signaling and immune response. Upamostat is characterized by its ability to modulate proteolytic activity, thereby influencing tumor progression and viral replication. Its chemical structure includes functional groups that contribute to its binding affinity and specificity for target proteases. As research continues, Upamostat's pharmacokinetics, efficacy, and safety profile are being evaluated to better understand its potential as a therapeutic agent. Overall, Upamostat represents a promising candidate in the ongoing search for effective treatments in oncology and virology.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Upamostat
CAS:Upamostat is an inhibitor of a serine protease and is a urokinase plasminogen activator (uPA) inhibitor.Formula:C32H47N5O6SPurity:99.41%Color and Shape:SolidMolecular weight:629.81WX 671
CAS:<p>WX 671 is an oral prodrug that is metabolized to the active compound, WX 672. It has potent anticancer effects and inhibits the growth of cancer cells by blocking the enzyme activity. The biological sample was collected from a fetal bovine and was found to inhibit squamous carcinoma in rats. WX 671 also has clinical relevance as it has been shown to induce apoptosis in tumor cells and inhibit inflammatory bowel disease (IBD). !--</p>Formula:C32H47N5O6SPurity:Min. 95%Molecular weight:629.81 g/mol
